Which of the following is NOT a side effect of co-careldopa?

Co-careldopa, a combination medication used primarily to treat Parkinson's disease, can indeed lead to several side effects, some of which are more common than others. Among these, nausea and vomiting, loss of appetite, and postural hypotension are well-documented.

When examining the side effects, nausea and vomiting are prevalent due to the dopaminergic effects of the drug. Loss of appetite may also occur, as it is not uncommon for patients taking dopaminergic medications to experience changes in their eating habits and overall appetite.

Postural hypotension is another recognized side effect of co-careldopa. This condition occurs when a person experiences a drop in blood pressure upon standing, which can lead to dizziness or fainting. This is particularly relevant in patients with Parkinson's disease, who may already have a compromised autonomic nervous system.

In contrast, increased energy levels is not a noted side effect of co-careldopa. This medication typically aims to alleviate the motor symptoms associated with Parkinson's disease rather than enhance energy. Patients may experience fluctuations in energy levels due to the disease itself and the medication's effects, but it does not directly promote increased energy. Thus, identifying increased energy levels as not being a side effect aligns with the pharmacological profile of